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Summary.-The design, and complications seen during the first 2 years, of a
randomized trial ofpostoperative radiotherapy for rectosigmoid cancer Dukes' B and
C are presented and discussed. It is concluded that the present complication
rate-below 10% in 221 patients-permits continuation of the intake, which is
planned to include 550 patients, to demonstrate a possible increase in crude 5-year
survival by 15o% (60-75o% in Dukes' B and 25 40o% in Dukes' C), on the basis of a 0-01
significance level and a probability that the experiment will be successful of0 90.
LOCAL RECURRENCE RATES after surgery
for rectosigmoid cancer amount to 5000 at
necropsy (Gunderson, 1976). This high
figure seems to be lowered by post-
operative radiotherapy (Turner et al.,
1977; Withers & Romsdahl, 1977) and the
5-year survival rate maypossibly be higher
in patients with rectosigmoid cancers
Dukes' B (Mendiondo et al., 1976) as well
as Dukes' C (Cohen et al., 1977; Turner et
al., 1977). However, the results of pro-
spective, randomized trials are not
yet available (Priestman, 1977; CGreen,
1981).
Lethal complications after a dose of
45-55 Gray are probably uncommon, but
peritoneal adhesions, intestinal stenoses
and perforations demanding repeated
surgery may occur in 5-10% of patients
(Russell & Welch, 1979; Ghossein et al.,
1981). Postoperative radiotherapy may be
preferred because of well-defined localiz-
ation of tumour during surgery, smaller
amounts of tumour tissue than before
surgery and avoidance of radiotherapy in
patients with Dukes' A tumours and
patients with distant metastases, diag-
nosed during surgery. On the other hand,
postoperative radiotherapy may be post-
poned because of surgical complications,
tumour spread may occur preoperatively
and the blood supply of tumour tissue left
behind may be reduced.
The present study was designed to
demonstrate a possible gain of 15% in 5-
year survivors after postoperative radio-
therapy in patients with rectosigmoid
cancer Dukes' B and C, with the proviso
that the trial cease if severe complications
after radiotherapy were seen in more than
10% of the patients. The design and
complications observed during the first 2
years of the trial are reported herein, and
the question as to whether the preliminary
results justify continuation of the study is
discussed.
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PATIENTS AND METHODS
Patients with rectosigmoid cancers Dukes'
B and C, located in the small pelvis, as
evaluated during surgery and operated upon
electively and radically in 5 surgical depart-
ments, were included in a prospective
randomized study which began in September
1979 (Table I). All other patients with
rectosigmoid cancer referred to the 5 depart-
ments were included in the prospective study,
but without randomization.
The radiotherapy was given in 3 regional
departments of oncology, using the same
technique.
Before surgery.-The patients were sub-
jected to proctoscopy, barium enema and/or
colonoscopy, X-ray of the chest and double
measurement of plasma carcinoembryonic
antigen (CEA) on 2 different days.
During surgery.-The size and localization
ofthe cancer in relation to the intestine, other
organs, peritoneum and upper pelvic border
were described on a special form. Metastases
and/or enlarged para-aortic lymph nodes were
biopsied and synchronous cancers treated
surgically. Low anterior rectal resection was
performed, when it was possible to resect 5 cm
below the cancer.
After surgery.-The bowel specimen was
opened immediately after removal, pinned
out on cork and fixed in formaldehyde. The
extent of invasion as well as size and
localization ofthe tumour was registered and
lymph nodes were examined and divided into
two groups: one within two parallel sections,
5 mm proximal and distal to the tumour, and
another outside that area. Sections were made
from the margins ofthe specimen, the central
part ofthe tumour and from all lymph nodes.
The tissues were embedded in paraffin and
sections were stained with haematoxylin and
eosin. Dukes' classification was used:
A: Tumour spread into submucosa or muscu-
laris externa without penetration; lymph
nodes not involved.
B: Tumour spread beyond muscularis externa
into the perirectal or pericolic tissue, but
without involvement oflymp nodes.
C: Lymph node metastases present.
D: Distant metastases present.
All tumours that did not penetrate muscularis
externa (all Dukes' A and some Dukes' C)
were divided into serial blocks and the whole
tumour was embedded and examined.
Randomization.-This was effective when
the following criteria were fulfilled:
1. The tumour had been removed and
classified as Dukes' B or C.
2. No microscopic tumour invasion in
borders ofresected specimen.
3. No enlarged para-aortic lymph nodes
with microscopically verified metastases.
4. No distant metastases.
5. No previous cancer within 5 years
(except baso- and spinocellular cutaneous
carcinomas).
6. No previous radiotherapy to the small
pelvis.
7. No postoperative complications post-
poning eventual radiotherapy more than 60
days from surgery.
8. Age less tan 80 years.
9. Bed-ridden less than 50% of day 20-25
days after surgery.
Informed consent was obtained after
randomization in patients being allocated to
postoperative radiotherapy and the treat-
ment was usually started within 30 days of
surgery, but could be postponed for 60 days
after surgery. Patients with Dukes' B
tumours were allocated at random to post-
operative radiotherapy and were stratified
according to type of surgery (rectosigmoid
resection or abdominoperineal excision) and
age (less than 50 years and 50 years or more).
The same principle was followed in patients
with Dukes' C tumours, as a group per se.
Plasma CEA was measured 4 and 10 days
after surgery.
Radiotherapy.-The patients were treated
in a prone position to give better access to the
perineal region and to reduce the dose to the
bladder and small intestine and the colost-
omy. The target volume includes the pelvic
cavity with the internal, external and
common iliac lymph nodes and extends to the
middle of the fifth lumbar vertebra. After
abdominoperineal excision the perineal region
was included. The urinary bladder was partly
excluded from the target volume.
A 3-field technique was used, 1 field from
behind and 2 parallel, opposing fields, 1 from
each side. The dose in the target volume was
equalized by wedges. A total target dose of
50 Gy was given in daily fractions of 2 Gy, 5
days a week. The treatment was given as a
split-course during 7 weeks, with a free
interval of2 weeks after30 Gy. An 8-16 mega-
V linear accelerator was used.
A special form was used to register the
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course of radiotherapy, including possible
deviations and side effects.
Follow-up :-All patients with rectosigmoid
cancer were seen in the 5 surgical departments
6, 12, 24, 36, 48 and 60 months after surgery.
A clinical examination including possible
rectovaginal exploration and measurement of
plasma CEA was always performed and a
special form including signs of complications
and recurrences was also completed. Procto-
scopy was done at each follow-up when an
abdominoperineal excision had not been
performed, andabariumenemaorcolonoscopy
was done 12, 36 and 60 months after surgery.
Patients with recurrent cancer in the
perineal region were treated with radio-
therapy, if this had not already been
effectuated by randomization. Patients with
recurrence in the vicinity ofanastomoses were
subjected to laparotomy and an attempt to
remove the recurrence; ifthis was impossible,
radiotherapy was given, provided that the
patient had no previous radiotherapy, and
afterwards the patient was re-evaluated as a
possible candidate for surgery.
Carcinoembryonic anttigen. - Duplicate
samples were taken as EDTA plasma, and the
analysis was carried out by the dialysis assay
ofHoffinan-La Roche.
The results ofCEA measurements in indivi-
dual patients will not be known to the
surgeons and oncologists before the patients
have been followed for 5 years; this allows for
evaluation of the prognostic value of CEA
measurements.
Stati8tic8 and evaluation.-The trial investi-
gates whether adjuvant radiotherapy will
increase the chance of 5-year crude survival
by at least 15% in patients with rectosigmoid
cancer Dukes' B (from approximately 60 to
75%) and Dukes' C (from 25 to 40%). The
significance level decided upon (ac) is 0 01 and
the desired probability (P) that the experi-
ment will be successful 0 90. To satisfy these
conditions, inclusion of 248 patients with
Dukes' B tumours and 253 with Dukes' C
tumours is necessary (Sokal & Rohlf, 1969).
In all, 550 patients (275 Dukes' B and 275
Dukes' C) will ultimately be included in the
randomized trial, but all patients with
rectosigmoid cancer will be registered and
followed in the same way.
Differences in morbidities and recurrences
will be evaluated by the x2 test, while
differences in survival will be evaluated by
the log-rank test.
RESULTS
The total number of patients included
during the first 26 months are listed in
Table I. Reasons for excluding patients
with Dukes' B and C tumours from
randomization are given in Table II.
TABLE I.-All patients with rectosigmoid
cancer Dukes' B and C from September
1979 to october 1981
Dukes' B
Dukes' C
Total
Randomized
number
129
92
221
Non-randomized
number
92
52
144
TABLE II.-Patients with Dukes' B and C
tumours, excludedfrom randomization
Tumour above the pelvis
No radical surgery
Other cancer within 5 years
Previous radiotherapy
Postoperative complications
Postoperative death
More than 80 years old
More than 50% oftime in bed
Others
Total
Dukes' B
number
27
3
6
4
8
4
19
12
9
Dukes' C
number
10
7
2
1
7
2
15
2
6
92 52
TABLE III.-Treatmentsfollowing
randomization
Number
Dukes' B
Dukes' C
Radiotherapy~~~~~A
Completed Partially No
radio- com- radio-
therapy pleted therapy
48 6 3
32 7 2
No
radio-
therapy
65
46
Randomized treatments are presented
in Table III. The number of patients
differs from that in Table I, since a small
number of patients (7 Dukes' B and 5
Dukes' C) have not yet finished radio-
therapy. In spite of allocation to radio-
therapy, 5 patients did not have this
treatment, because of refusal (2), anasto-
motic leakage (1), perineal abscess (1) and
deterioration (1). Reasons for not com-
pleting radiotherapy are given in Table
IV.
Severe complications registered during
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TABLE IV. Reasons for incomplete zation open to criticism. However, it is
radiotherapy difficult to select any ofthe groups in table
Number II for randomization. Allowing radio-
Dukes' B therapy to begin more than 60 days after
Tleus because ofadhe-sions I surgery and thereby including most
Abdominal pains 1 with postoperative complications Diarrhoea 1 patients
'Perineal dermatitis 1 would increase the number of patients by
AMental depression 1 o
Detection of pulmonary cancer I only a few per cent. Some patients more
than 80 years old would probably tolerate
Dukes' C radiotherapy, but the majority would not Ileus because of adhesions I benefit. The large group of patients with
Ileus (no reoperation) 2
Diarrhoea 3 tumours in the sigmoid above the pelvis Deterioration 1 would not benefit from radiation within
the small pelvis, which is the only area
the first 26 months in randomized patients considered in the present study.
are presented in Table V, excluding those The reasons for exclusion are not very
appearing during radiotherapy (Table IV). restricted and the number of patients
The preliminary status of local recur- available for randomization could be
rences and survival for patients with further diminished by excluding patients
Dukes' B and C tumours observed for at with asthenic stature, cardiovascular
least 6 and at most 24 months is seen in disease, diabetes mellitus and previous
Table VI. pelvic surgery, all of whom may have an
Pre- and early postoperative CEA increased risk of radiation injury of the
values were obtained in most of the small intestine (Swan et al., 1976; Loiudice
patients and correlated positively with et al., 1977). The reasons for exclusion used
Dukes' classification. in the present study have resulted in a
higher lethality in patients with Dukes' B
DISCUSSION and C tumours in whom randomization was not performed (Table VI). Twenty-
No more than 370 of the patients with four per cent of patients with Dukes' B
rectosigmoid cancer could be considered and 29% of those with Dukes' C tumours
potential candidates for radiotherapy and excluded from randomization have
the substantial number with Dukes' B already died, which emphasizes the high
ande C tumours excluded from randomi- risk in these 2 groups.
zation (42% with Dukes' B and 36% with The figures in Table III clearly demon-
Dukes' C) make the criteria of randomi- strate that the present postoperative
TABLE V.-Severe complications in randomized patients during first 26 months after
surgery, excluding those complications listed in Table IV, but includingpatients allocated
to radiotherapy, where this was given or not
Number (total)
Ileus because of adhesions
Stenosis of ileum
Stenosis of ileum and sigmoid
Perforation of ileum and stenosis of sigmoild
Anastomotic leakage
Subphrenic abscess (fatal)
Suicide (recurrent cancer)
No complication
I)ukes' B ran(lom
A
+Radiotherapy None
57 65
0~~~~
1. I
Dukes' C random
+ Radiotherapy None
41 46
1 2
1
I
40 42
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TABLE VI.-Local recurrences and survival in patients with Dukes' B and C tumours
observedfor at least 6 and at most 24 months
Died
Possibly
Total Local With with Without
number recurrence cancer cancer cancer
Dukes' B
Randomized
+radiotherapy 44 5 5 1 0
- radiotherapy 54 3 3 0 0
Non-random 73 11 3 2 13
Dukes' C
Randomized
+radiotherapy 35 1 2 1 0
-radiotherapy 31 6 5 0 1
Non-random 44 8 8 3 2
radiotherapy programme is not feasible in
all patients. Only 85% ofthose who began
the therapy had a complete course of
radiation; most reasons for breaking the
radiotherapy were directly related to
expected side effects (ileus, diarrhoea,
perineal dermatitis). A similar proportion
of patients completing radiotherapy was
seen in a previous randomized study of
preoperative radiotherapy (Roswit et al.,
1973).
Severe complications developing after
radiotherapy were not significantly more
frequent than in patients receiving no
radiotherapy (Table V) and only 3 of the
98 (57 +41) patients allocated to radio-
therapy had complications which were
undoubtedly due to radiotherapy (intesti-
nal stenosis and perforation). This low
figure is similar to those in two recent 10-
year reviews of major intestinal compli-
cations following radiotherapy to the
abdomen, pelvis and perineum (Cram et
al., 1977; Deitel & Vasic, 1979). The
present figure may rise during the follow-
ing years and should possibly be
considered higher than stated, including
those complications which caused the
cessation of radiotherapy before the full
dose was given (Table IV). However,
nearly all of these complications were
reversible and none was lethal. Rectal
bleeding and persisting bladder symptoms
were not registered.
No prospective comparisons of compli-
cations in patients treated with and with-
out postoperative radiotherapy are
available, but it has been stated that
complications after preoperative radio-
therapy are not more frequent than in
surgical series (Stevens et al., 1976).
The present series is expectedto serve as
an estimate of possible increased risks of
complications after postoperative radio-
therapy. So far, the steering committee of
the trial considers it justifiable to con-
tinue the intake of patients, since the
frequency of complications is not greater
than that agreed upon.
The frequencies of local recurrence may
possibly be lower after radiotherapy, at
least in patients with Dukes' C tumours
(Table VI), and a gain in 5-year survivors
can be anticipated, but it will take several
years before these suggestions can be
finally evaluated.
This trial is supported by grants from the Danish
Cancer Society.
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